FIB-4 Indeterminate: What Comes Next in Practice?
Operational discussion of how clinics handle indeterminate FIB-4 results and when non-invasive staging pathways are considered.
Indeterminate FIB-4 results are common in real clinics and often trigger uncertainty about next-step testing.
This page discusses workflow options at a systems level, not patient-specific medical advice.
Typical next-step decision points
Clinics usually decide how quickly to escalate, what non-invasive staging method to use, and how to close the loop with documented follow-up.
Delays often happen when pathway ownership is unclear or capacity is fragmented across sites.
Why bridge content matters
Educational demand pages create awareness, but bridge pages connect that awareness to practical comparison and implementation decisions.
For procurement teams, the next step is often device workflow review, cost modelling, and training feasibility.